The long-term objective of this project is to understand the relationship between the molecular structure of the mitochondrial citrate transport protein (CTP) and its mechanism of transport. This transporter catalyzes the exchange of tricarboxylates, dicarboxylates, and phosphoenolpyruvate across the inner mitochondrial membrane, and as such is essential to the energy metabolism of eukaryotic cells. Recently, we: i) conducted cysteine scanning mutagenesis studies of transmembrane domains (TMDs) HI and IV which, in combination with chemical modification, nitroxide scanning, and substrate protection experiments, permitted identification of essential portions of the substrate translocation pathway;ii) developed a homology model of the CTP structure;and iii) developed methods for the purification of the CTP in crystallization-compatible detergents, which enabled the initiation of comprehensive crystallization trials. From this foundation, we propose to launch studies that will continue the fundamental advancement in our understanding of the functioning of this metabolically important transporter. Specifically, experiments will be conducted to: i) define the contributions of the four remaining TMDs in the formation of the CTP substrate translocation pathway (via cysteine-substitution mutagenesis at locations chosen on the basis of our homology modeled CTP structure followed by chemical modification of the single Cys mutants) and identify residues forming an electrostatic funnel that attracts citrate into the pathway from its surfaces;ii) identify the substrate binding site(s) within the translocation pathway and assess the ability of selected CTP domains to control substrate access to the pathway;iii) identify residues forming the interface between two CTP monomers in homodimeric CTP and characterize the ligand-induced conformational changes that occur during transport using site-directed spin labeling and thiol cross-linking;and iv) identify conditions enabling the growth of X-ray diffraction quality CTP crystals followed by determination of the CTP structure. These studies will provide a comprehensive understanding of the chemical and structural bases for mitochondrial CTP function. The health relatedness of this project concerns the central role of the CTP in bioenergetics. Thus, altered CTP function in disease (e.g., diabetes, cancer) is an important aspect of the aberrant metabolism that characterizes these pathologies. Consequently, an elucidation of the structural basis for substrate transport through the CTP is critical to understanding the CTP's role in energy production in normal and pathological states.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM054642-13S1
Application #
7932586
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Anderson, Vernon
Project Start
2009-09-30
Project End
2011-03-31
Budget Start
2009-09-30
Budget End
2011-03-31
Support Year
13
Fiscal Year
2009
Total Cost
$130,480
Indirect Cost
Name
Rosalind Franklin University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
069501252
City
North Chicago
State
IL
Country
United States
Zip Code
60064
Mayor, June A; Sun, Jiakang; Kotaria, Rusudan et al. (2010) Probing the effect of transport inhibitors on the conformation of the mitochondrial citrate transport protein via a site-directed spin labeling approach. J Bioenerg Biomembr 42:99-109
Sun, Jiakang; Aluvila, Sreevidya; Kotaria, Rusudan et al. (2010) Mitochondrial and Plasma Membrane Citrate Transporters: Discovery of Selective Inhibitors and Application to Structure/Function Analysis. Mol Cell Pharmacol 2:101-110
Aluvila, Sreevidya; Sun, Jiakang; Harrison, David H T et al. (2010) Inhibitors of the mitochondrial citrate transport protein: validation of the role of substrate binding residues and discovery of the first purely competitive inhibitor. Mol Pharmacol 77:26-34
Aluvila, Sreevidya; Kotaria, Rusudan; Sun, Jiakang et al. (2010) The yeast mitochondrial citrate transport protein: molecular determinants of its substrate specificity. J Biol Chem 285:27314-26
Remani, Sreevidya; Sun, Jiakang; Kotaria, Rusudan et al. (2008) The yeast mitochondrial citrate transport protein: identification of the Lysine residues responsible for inhibition mediated by Pyridoxal 5'-phosphate. J Bioenerg Biomembr 40:577-85
Ma, Chunlong; Remani, Sreevidya; Sun, Jiakang et al. (2007) Identification of the substrate binding sites within the yeast mitochondrial citrate transport protein. J Biol Chem 282:17210-20
Ma, Chunlong; Remani, Sreevidya; Kotaria, Rusudan et al. (2006) The mitochondrial citrate transport protein: evidence for a steric interaction between glutamine 182 and leucine 120 and its relationship to the substrate translocation pathway and identification of other mechanistically essential residues. Biochim Biophys Acta 1757:1271-6
Ma, Chunlong; Kotaria, Rusudan; Mayor, June A et al. (2005) The yeast mitochondrial citrate transport protein: characterization of transmembrane domain III residue involvement in substrate translocation. J Biol Chem 280:2331-40
Cascio, Michael; Mayor, June A; Kaplan, Ronald S (2004) Analysis of the secondary structure of the cys-less yeast mitochondrial citrate transport protein and four single-cys variants by circular dichroism. J Bioenerg Biomembr 36:429-38
Ma, Chunlong; Kotaria, Rusudan; Mayor, June A et al. (2004) The mitochondrial citrate transport protein: probing the secondary structure of transmembrane domain III, identification of residues that likely comprise a portion of the citrate transport pathway, and development of a model for the putative TMDIII-TMDIII J Biol Chem 279:1533-40

Showing the most recent 10 out of 18 publications